Bio-Intelligence Chips (BIC)

IARPA is interested in developing an ability to rapidly assess an individual's potential involvement in chemical or biological weapons (CBW) related activities. The Bio-Intelligence Chips Program (BIC) intends to develop new analytical approaches to assessment based on cross-correlating multiple biomarkers found in physiological fluids to assay human exposure to agents and activities indicative of CBW production and handling. BIC performers will identify signatures associated with specific threat hypotheses that comprise sets of biomarkers corresponding to exposures consonant with particular CBW involvement scenarios. BIC targets design and development of bioassays that can rapidly (in ≤30 min) identify biomarkers from a small amount of human sample (≤100 µL). It is not required that final results be demonstrated on a portable platform; however future scalability to a portable platform should be described. CBW threats of interest fall into three categories: a) virus, b) bacteria, and c) toxin-derived from bacteria or chemicals.

BIC is interested in omni-omic expressions encompassing, but not limited to, genomics, transcriptomics, proteomics, metabolomics, epigenomics, microbiomics, immunomics, glycomics, and lipodomics. The best known of these omics categories is genomics, which deals with bioinformatic data developed from the analysis of DNA sequences. The other categories include:

(1) transcriptomics, the analysis of information derived from RNA transcription levels of expressed genes within a cell population;

(2) proteomics, the analysis of expressed proteins and their associated modifications;

(3) metabolomics, the analysis of levels of metabolites (small organic molecules, including regulatory peptides) associated with the maintenance of homeostasis;

(4) epigenomics, the study of heritable changes that are not directly encoded in DNA sequences;

(5) microbiomics, the analysis of the species, numbers, and locations of parasitic and commensal organisms, e.g., bacteria that live endosymbiotically with their hosts;

(6) immunomics, the analysis of information pertaining to changes in the immune system, particularly those associated with adaptive immunity;

(7) glycomics, the analysis of all glycan structures in an organism including the glycan's interaction with lectins and other biomolecules; and

(8) lipodomics, the analysis of pathways and networks of cellular lipids in biological systems, including the quantification of lipids, the analysis of their conjugates (e.g., glycans) and their interactions with proteins, metabolites and other lipids.

The expected duration of the BIC program in its entirety is five years. This solicitation, however, seeks responses to only Phase I of the program, which will be 24 months in duration. During this period IARPA seeks to identify sets of omni-omic signatures for CBW threats of interest.

Contracting Office Address:

Office of the Director of National Intelligence
Intelligence Advanced Research Projects Activity
Washington, District of Columbia 20511
United States

For Information Contact:

dni-iarpa-info@iarpa.gov

 

 

Solicitation Status: Closed

Broad Agency Announcement (IARPA-BAA-13-04)
Proposers' Day Date: November 15, 2012
BAA Release Date: December 5, 2013
Proposal Due Date: January 29, 2014
BAA Closing Date: October 22, 2014

Additional Information